belapectin
GT-031
Phase 3 small_molecule terminated
Quick answer
belapectin for Prevention of Esophageal Varices is a Phase 3 program (small_molecule) at GALECTIN THERAPEUTICS INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- GALECTIN THERAPEUTICS INC
- Indication
- Prevention of Esophageal Varices
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- terminated